Abstract
Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 756-759 |
| Number of pages | 4 |
| Journal | American Journal of Psychiatry |
| Volume | 151 |
| Issue number | 5 |
| State | Published - May 1994 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Psychiatry and Mental health
Cite this
Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. / Liberman, Robert Paul; Van Putten, Theodore; Marshall, Barringer D.; Mintz, Jim; Bowen, Linda; Kuehnel, Timothy G.; Aravagiri, Manickan; Marder, Stephen R.
In: American Journal of Psychiatry, Vol. 151, No. 5, 05.1994, p. 756-759.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Optimal drug and behavior therapy for treatment-refractory schizophrenic patients
AU - Liberman, Robert Paul
AU - Van Putten, Theodore
AU - Marshall, Barringer D.
AU - Mintz, Jim
AU - Bowen, Linda
AU - Kuehnel, Timothy G.
AU - Aravagiri, Manickan
AU - Marder, Stephen R.
PY - 1994/5
Y1 - 1994/5
N2 - Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.
AB - Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.
UR - http://www.scopus.com/inward/record.url?scp=0028202507&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028202507&partnerID=8YFLogxK
M3 - Article
C2 - 8166320
AN - SCOPUS:0028202507
VL - 151
SP - 756
EP - 759
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
SN - 0002-953X
IS - 5
ER -